Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Conditions: Recurrent Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8 Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Lymphoscintigraphy; Procedure: Magnetic Resonance Imaging; Biological: Ramucirumab; Drug: Tepotinib Sponsors: SWOG Cancer Research Network; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Lung Cancer | Lymphoscintigraphy | Non-Small Cell Lung Cancer | Research